1. Introduction
The work conducted by honey bee workers for the benefit of humans and the ecosystem is invaluable. EFSA reports that the annual pollination by bees has been valued at around 22 billion Euros, and in Poland alone, this value exceeds 964 million Euros [
1,
2]. Worldwide, the economic value of pollination by honey bee workers has been estimated at 265 billion Euros per year [
3,
4]. Researchers have been searching for many years for factors that reduce losses in apiary management and increase the security of the honey bee as the main pollinator in the food production chain [
5,
6,
7]. Bee colonies are constantly threatened by brood and adult bee diseases, susceptibility to xenobiotics (including pesticides), an impoverished forage base, and lack of diverse protein food results in massive worker malnutrition (nutritional stress), environmental stress, and newer pests arriving from different parts of the world (populations of the small hive beetle or Asian hornet) [
8,
9]. The honey bee is also accompanied by a microflora whose biodiversity is modified by many environmental factors, including stress factors such as pesticides, forage shortages, pressure from the pathogenic microbiome, and immune impairment [
10,
11,
12]. According to various literature sources, there are between 6000 and 8000 different microbial strains in the microbiome of bee colonies [
13].
One microbial threat to the balance of the colony microbiome is
Paenibacillus larvae, a Gram-positive, peridomestic, mobile, virulent, flagellated, spore-forming bacterium highly adapted to its only known host; honey bee larvae that cause a brood disease are called American foulbrood [
14]. The bacteria
Paenibacillus larvae, which produces approximately one billion spores per infected larva, is the main vector of this disease [
15].
Increasingly, the so-called orphan bacteria, i.e., bacteria that are highly adapted to a specific host or extreme environment, are the object of scientific interest for many scientists. Such bacteria include the
P. larvae, which attack bee larvae that become infected through the activity of feeder bees and hub bees, which take care of the brood and provide food, often already contaminated with
P. larvae endospores. Due to ongoing proteolytic processes, the larvae are broken down into a purulent infectious mass. After drying, this mass continues to exhibit infectious properties. When most of the larvae are infected and die, the whole colony is sealed and collapses. The pathogenic bacteria become a natural opponent for the probiotic bacteria that are in the larvae’s native gut microbiome and can completely sterilize the microflora and dominate this environment through the expansion of
P. larvae. The metabolism of these bacteria shows that they can produce peptide antibiotics either through genes encoding for the synthesis of ribosomal peptides or through giant gene clusters encoding for enzyme complexes that non-ribosomally synthesize antimicrobial active peptides (NRP) or polyketides (PK). Gene clusters are responsible for producing low molecular weight compounds, such as bacillibactin, were identified. They act as an iron chelator, meaning that they bind iron in the environment, making it difficult for other microorganisms to access this element. This gives bacteria that produce bacillobactin an advantage in the competition for resources in a given ecosystem. The destructive effect of cytotoxins such as paenilarvins, in which antifungal properties have been confirmed against yeasts and filamentous fungi, or sevadicins or paenilamicins with bactericidal and fungicidal effects, is also suspected. The bacteriocins and antimicrobial compounds secreted by
P. larvae first eliminate the microbes in the intestine of the larvae, thus ensuring that the infection is only potentiated by the
P. larvae. During the colonization of the midgut lumen,
P. larvae peptide antibiotics (e.g., paenilamicin and iturin) eliminate bacterial and fungal microorganisms ensuring that
P. larvae are the only bacterium. In addition,
P. larvae secrete enzymes (lytic polysaccharide monooxygenases) that break down chitin, which protects epithelial cells. Specific toxins secreted by
P. larvae Eric II, i.e., Plx1, Plx2, or cytotoxic secondary metabolites secreted by both genotypes (paenilarvin by Eric II and paenilamicin secreted by Eric I/II) attack essential cellular functions and the bacteria are attached to exposed epithelial cells through the S-layer. Two important mechanisms should be considered: the degradation of chitin and the degradation of the midgut of larvae, which are estimated to be key steps in the pathogenesis of
P. larvae infection [
16].
Spores can survive for up to 50 years under favorable conditions and exhibit infectious properties for 35 years. A temperature of 100 °C destroys spores after 5 days, while at 140–170 °C they die after only 2 h. Spores are also killed in 5–10% formalin within 6 h, while soda lye kills spores at a concentration of 2% within 4 min. It has been found that 5% sodium hypochlorite is also effective. Vegetative forms die at 60 °C [
16,
17,
18]. An infected and disease-dead larva can contain up to 2.5 billion endospores, but only 10 to 35 spores are needed to infect another larva, indicating high virulence and a high rate of disease spread [
19,
20]. Spores can reside in honey, wax, royal jelly, propolis, pollen, and bee feathers. Once in the digestive tract of the larvae, they germinate after 24 h, leading to bacterial superinfection manifested by rapid growth of vegetative forms. The vegetative cells damage the epithelium and intestinal walls and later attack all internal organs leading to cytolysis and histolysis [
21,
22,
23]. Nine days after infection, spores begin to form. The maggots die after 2–3 days after the cell is sealed [
24]. The dead larvae become flaccid, changing color first to yellow, then to a brown, sticky, and malleable mass. Five serotypes of American foulbrood are currently recognized worldwide: Eric I, Eric II, Eric III, Eric IV, and Eric V [
25,
26].
The epizootiological agent for all varieties is the same bacterial species,
Paenibacillus larvae. Sick bee colonies are physically eradicated on the recommendation of veterinarians, legislation in the EU does not allow the use of any form of pharmacotherapy, and in Poland, American foulbrood is eradicated ex officio. In the past, antibiotics and sulfonamides were used. Currently, only administrative procedures are available for American foulbrood control [
27]. Once American foulbrood is confirmed, the district veterinarian may decide to eradicate the colonies or, in justified cases, order a double relocation procedure to a new or decontaminated hive on frames with hoses [
28]. Most cases with confirmed cases of foulbrood are classified as a high-risk group and end up with the burning of infected colonies. Prevention consists primarily of maintaining appropriate sanitary standards involving, for example, frequent changes in combs, and disinfection of hives and tools (e.g., with Virkon S produced by Bayer, active substance: pentapotassium bis(sulfate) bis(peroxymonosulfate)). Other prevention methods include descriptions of the use of essential oils: cinnamon, rosemary, thyme, lemon, or aniseed. The effect of extracts of various herbal species on
P. larvae cells is also known from in vitro laboratory studies [
29,
30]. Solutions described as effective in reducing
P. larvae abundance include products to be applied as food additives (syrup or cake) and products to be applied as sprays or sprinkled on the inter-frame streets [
31].
In Poland, there are no specific legal restrictions on the movement of migratory apiaries, which exacerbates the epidemiological situation.
The phenomenon of competition between microorganisms is well-known. Bacterial metabolites, also known as metabiotics, have become an object of scientific interest in recent years. Micro-organisms isolated from the digestive tracts of bees with in vitro antimicrobial activity against
P. larvae are described in the literature [
32,
33]. Such activity may be called bioassurance. The definition given by Zygmunt Pejsak includes specific indications to be implemented to reduce or eliminate the risk of pathogen transmission into the flock. The aim of bioassurance is, among other things, to reduce the risk of introducing an infectious agent into the herd [
34]. In the definition of another researcher Thomas Gillespie, bioassurance must reduce the risk of pathogen intrusion and must consist of bioexclusion, which will control the transmission of pathogens. This element of bioassurance has been referred to as biocontainment [
35]. Bioassurance is the so-called biological protection consisting of protecting the animals through preventive and sanitary measures using biocontainment on the farm as well as in the immediate surroundings [
36,
37]. Biotisation as a tool for the introduction of bioassurance may be a new biotechnological approach to animal husbandry. It consists of inoculating the animal environment with beneficial micro-organisms such as fungi or bacteria to increase their dominance in the environmental microbiome by increasing the tolerance of animals to biotic and abiotic stresses (in practice this is spraying or fogging) [
38,
39,
40]. Beneficial micro-organisms, also known as beneficial or effective microorganisms (EM), have an important function in restoring the microbial balance in the native microbiome of animals and also supply animals with valuable metabolites and protect them from pathogens [
40,
41].
The lack of effective product solutions on the market to prevent the development of superinfection, the unstable administrative and legal status of American foulbrood, the risky practices of beekeepers and growers exacerbating the American foulbrood problem, the increased interest on the market in natural products like targeted microbial biopreparations with increased metabolite content, the untapped potential of biotechnology and microbiology in the control and prevention of livestock diseases and animal welfare are just some elements of why this topic of work was undertaken.
The complexity of the research problem concerns is as follows: (1) the reduction in American foulbrood pressure in bee colonies by supporting the development of the physiological microbiome of honey bee larvae, competing with and blocking the excessive proliferation and production of P. larvae endospores; and (2) testing the sensitivity of P. larvae vegetative cells to biologically active substances, constituted by biotechnological processes aimed at obtaining a high content of bioactive compounds in the final product using bacterial probiotic components.
The aim of the study was (1) to test the biological activity of selected bacterial components with confirmed probiotic potential that could constitute the composition of a pilot pre-formulation of future metabolic preparation, and (2) to compare the antimicrobial activity of inoculants and post-culture (post-fermentation) fluids of selected, functional bacterial strains against Paenibacillus larvae Eric I ATCC 9545 (Labiol) and Eric II CCUG 48973 (Labiol).
The overall scope of the work involves making inoculants of functional bacterial strains by revitalizing the bacterial strains by hydration of lyophilizes according to in-house procedures, then carrying out the actual multiplication (fermentation) in glass bioreactors and obtaining the first half pre-formulations on a laboratory scale. This consisted of transferring the functional bacteria cultures to selected media and multiplying by a technological process aimed at obtaining bioactive metabolites. The final step was to determine the antimicrobial activity of the culture fluids by establishing the inhibition zones of the indicator strain. This was performed by inoculating bloody agar with a suspension obtained from the selective multiplication of biological material on selective nutrient slants for P. larvae. Results were presented after 48–72 h of incubation at 37 °C.
4. Discussion
The environmental microbiota is constantly disrupted due to various environmental factors, so the constant supplementation with probiotics (agriculture, veterinary, and medicine) seems justified. In line with the provisions of the European Field-to-Table Strategy and the Green Deal, a reduction in the use of antibiotics in the ecosystem cycle is recommended. This is also indirectly related to increasing antibiotic resistance [
44,
45].
Also, in the environment of the honey bee population, there is a continuous reduction in beneficial microbes. Despite prohibitions, beekeepers often use prohibited antimicrobial substances, including antibiotics, which then easily pass into bee products and become a real threat to consumers in the food safety chain. To overcome these problems, steps should be taken to develop a leak-proof prevention system and to implement natural product solutions, which could contain proven functional microorganisms, metabolites, or plant extracts to displace and reduce the pressure of pathogens from the bee colonies’ physiological microbiome. The research undertaken in this study has achieved TRL Technology Readiness Level III and will certainly continue to develop an effective composition to reduce bacterial superinfections caused by Paenibacillus larvae.
Researchers searching for microbial antagonistic agents for American foulbrood biocontrol are most often limited to testing strains from the genera
Lactobacillus and
Bifidobacterium. Studies in which bacteria isolated from healthy bee colonies have been also encountered. These are specific microorganisms derived from the microbiome of bee colonies and usually involve the genera
Bacillus sp.,
Streptococcus,
Candida sp.,
Saccharomyces,
Pseudobacterium,
Fructobacillus,
Parasaccharibacter,
Ochrabactum,
Acinetobacter,
Stenotrophomonas,
Gilliamella,
Snodgrassella,
Actinomadura,
Streptomyces,
Apilactobacillus,
Bombilactobacillus, and many others. As there are between 6000 and 8000 different microbial strains in the bee microbiome, it seems nothing new or harmful to administer specific probiotics and supplement the microflora. In human medicine, the effect of so-called probiotic interventions and the administration of specific strains to support, for example, diabetes, cancer, or obesity, modifying the diseased microbiome, is increasingly being studied. Diagnostic tests based on the presence of specific microorganisms as biomarkers are also being developed [
46,
47,
48,
49].
The results from the comparative analysis of the antimicrobial activity of culture fluids of selected probiotic bacterial species against
Paenibacillus larvae belonging to Eric I and II genotypes under in vitro conditions are consistent with literature data and tests evaluated by E. Forsgren, S. Lamei, and T. Olofsson [
50,
51,
52]
High efficacy in antimicrobial activity was also achieved in a 2006 study conducted by Alippi and Reynaldi, confirming high antimicrobial activity for
Bacillus pumilus,
Bacillus licheniformis, and
Bacillus megaterium against
P. larvae ATCC 9545 [
53].
Audisio et al. described the effective combination of a
Bacillus subtilis strain with a plant extract against
P. larvae highlighting the high utility of
Bacillus spp. [
54].
Also, Bartel and Alippi in 2018 identified natural antagonists of
P. larvae by selecting strains of
Bacillus species and related genera producing a broad range of antimicrobial compounds, with activity against bacteria and fungi that include peptides, lipopeptides, bacteriocins, and bacteriocin-like inhibitory substances. By using biological tools, they evaluated the antagonistic activity of 34 bacterial strains against
Paenibacillus larvae and
Ascosphaera apis, the causal agents of American Foulbrood and Chalkbrood diseases of honey bee larvae, respectively. In the work in question, a strong bactericidal effect attributed to a strain of
Bacillus megaterium and
Bacillus licheniformis was demonstrated. Similarly, in studies by other researchers,
B. megaterium showed strong antimicrobial activity due to the production of megacins by
Bacillus megaterium and lichenin and lichenicidin produced by
Bacillus licheniformis [
55].
Studies by other authors have documented that
Bacillus licheniformis and another strain tested in the experiment reduced the mortality of American foulbrood-infected larvae. Treatments showed positive effects and reduced mortality [
56].
Many studies by other authors confirm the efficacy of the bacterial species analyzed in reducing American foulbrood. This demonstrates the pertinent and successful selection of bacterial strains that can find application in the prevention of this disease. In other studies,
B. licheniformis and
B. subtilis also showed antimicrobial activity against
P. larvae isolated from the bee environment in Saudi Arabia [
57].
There are no sources that report what antagonistic effect
Streptomyces narbonensis species may have. Korean researchers demonstrated that isolates extracted from forest soil, also identified as human pathogens, containing mainly strains of the genus
Streptomyces showed strong pressure and antimicrobial activity against
Paenibacillus larvae isolates supporting the theory that the source of the search for microbial agents need not only be the healthy bee microbiome but also other sources and natural resources [
58].
Bacterial metabolites are reported in detail by Adrian A. Pinto-Tomas and co-workers, who isolated
Actinobacteria in the genus
Streptomyces from foraging bees, and especially common in pollen stores. One strain, isolated from pollen stores, exhibited pronounced inhibitory activity against
Paenibacillus larvae [
59].
Q. Jamal, on the other hand, describes the widespread use of bacteria of the genus Lysinibacillus. Moreover, some Lysinibacillus species have antimicrobial potential due to bacteriocins, peptide antibiotics, and other therapeutic molecules.
This shows a well-chosen vector of search and selection of strains for the work in question. Good probiotic properties, high survival rates, and origin from the hive microbiome are reported by Polish researchers in the context of
B. pumilus and
B. licheniformis which again shows the correct selection in microbial agents for biocontrol of American foulbrood. Therefore, it is confirmed that
B. pumilus and
B. licheniformis species also occur in the hive environment [
60].
Levilactobacillus brevis also shows the ability to reduce the biofilm formation of
P. larvae isolated from honey bee guts or fresh pollen samples, as indicated by the mechanism of action of this species [
61].
In a study by Polish scientists,
Levilactobacillus brevis B50 increased the expression of pattern recognition receptors and genes encoding antimicrobial peptides (defensin-1 and abaecin [
62]. The LAB isolated from the honey bee gut has been demonstrated to be helpful for the inhibition of
P. larvae. The antibiotic action of
L. brevis is also based on its secretion of organic acids [
63,
64].
By testing bacterial growth under bioreactor conditions on a semi-industrial scale, it was shown that the most promising bacteria with the highest antimicrobial activity can be cultured on a large scale in the future. The research presented in this paper is distinguished by the fact that the antimicrobial properties of the functional strains were tested not on laboratory media as is the case with most available studies and publications, but scaled up to a larger production scale, and only then were these antimicrobial properties reproduced and confirmed on industrial media. Therefore, this is an added value to the present work. It should also be ensured in further stages that these results are validated under in vivo conditions by checking that the antimicrobial properties are also confirmed on living organisms (larvae and bees).